Monoclonal antibody treatment for COVID-19 stands safe in pregnancy: Study Dr. Kamal Kant Kohli28 Nov 2022 4:15 AM GMTPennsylvania : A single-center study published in Annals of Internal Medicine found that monoclonal antibody therapy for COVID-19 was safe to use...
Medical Bulletin 19/November/2022 Dr. Nandita Mohan19 Nov 2022 8:30 AM GMTHere are the top medical news for the day:Ultrasound-guided surgery is quicker, less painful and more effective for treating early form of breast...
Studies provide latest 'real world' evidence on effectiveness of covid-19 treatments Dr. Nandita Mohan19 Nov 2022 5:00 AM GMTThe debate around the effectiveness of COVID-19 treatments has been ongoing and often appears never-endingTwo studies published by The BMJ today...
Sotrovimab effective treatment option for COVID-19 infection in Kidney Transplant Recipients Dr. Kamal Kant Kohli25 Oct 2022 12:30 PM GMTSPAIN: According to research published in Clinical Kidney Journal, the monoclonal antibody sotrovimab can be safely utilized in kidney transplant...
COVID-19 Treatment: GSK Sotrovimab, Roche antibody cocktail casirivimab-imdevimab no longer recommended by WHO Ruchika Sharma22 Sep 2022 10:44 AM GMTBoth therapies continue to be recommended for use by the European drugs regulator.
Sotrovimab effectively cuts progression of COVID-19 in nonhospitalized, high-risk patients: JAMA Dr. Shravani Dali9 April 2022 6:15 AM GMTSotrovimab can be used as an effective treatment option for non-hospitalized, high-risk patients with mild to moderate COVID-19, according to a...
GSK-Vir COVID therapy Sotrovimab authorization junked by USFDA Roshni Dhar8 April 2022 5:47 AM GMTThe U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment,...
Health Bulletin 7/April/2022 Roshni Dhar7 April 2022 12:21 PM GMTHere are the top health stories for today: Health Ministry denies detection of XE variant in India In response to the media reports that...
USFDA junks authorization of GSK- Vir COVID therapy Sotrovimab Ruchika Sharma6 April 2022 10:50 AM GMTSotrovimab is no longer authorized to treat COVID-19 in any US region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2...
USFDA amends emergency use authorization for Sotrovimab due to Omicron BA.2 Subvariant Ruchika Sharma27 March 2022 4:45 AM GMTSan Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have announced that the US Food and Drug Administration (USFDA) has amended...
Sotrovimab, A Potential Treatment Option Non-Hospitalized High-Risk COVID Patients MD Bureau15 March 2022 2:29 PM GMTAs of January 2022, more than 5.4 million people worldwide have died from COVID-19. Effective therapies are needed because of mutations, limited...
WHO panel recommends Eli Lilly Baricitinib, GSK-Vir Biotechnology drug for COVID treatment Ruchika Sharma14 Jan 2022 10:29 AM GMTNew Delhi: The World Health Organization on Friday gave a nod to two new drugs for the treatment of COVID-19 patients with severe and non-severe...
